Inventor
PHILIP D. GREGORY
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
C12NMicroorganisms or enzymes23%
A61KPreparations for medical, dental or toiletry purposes13%
C12YEnzymes10%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
11,884,930Method of inactivating a glucocorticoid receptor gene in an isolated cell202411,661,612DNA-binding proteins and uses thereof202311,649,468Targeted integration into the PPP1R12C locus202311,492,643Methods and compositions for treatment of a genetic condition202211,439,666Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases202211,235,026Methods and compositions for modulating PD1202211,236,175T cell modifying compounds and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to SANGAMO THERAPEUTICS INC (7)· patent assignee history
2022Patents assigned to OSPEDALE SAN RAFFAELE SRL (1)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to HOPE CITY (1)· patent assignee history
2024Patents assigned to SANGAMO BIOSCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SANGAMO THERAPEUTICS INC | 7 | 2022–2024 |
| HOPE CITY | 1 | 2024 |
| OSPEDALE SAN RAFFAELE SRL | 1 | 2022 |
| SANGAMO BIOSCIENCES INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2024 |